Plant Virus-Based Nanoparticles as an Adjuvant for the Development of an Efficient and Low-Cost Vaccine Against Malaria

Despite years of intensive efforts using conventional approaches to vaccine design, there is currently no effective vaccine against malaria. New approaches are crucial. The ""Plant virus based nanoparticles as an adjuvant for the development of an efficient and low cost vaccine against malaria"project aims to use nanoparticles derived from papaya mosaic virus (PapMV-NP) as an adjuvant to develop a novel malaria vaccine that would be safe, efficacious and low-cost.